SCHEMBL17088191

SCHEMBL17088191

CCOc1ccc(-c2n[nH]cc2-c2ccncc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.52
KDM4E B2RXH2 5/20 0.52
NPC1 O15118 5/20 0.52
RAB9A P51151 5/20 0.52
KMT2A Q03164 3/20 0.52
HSD17B10 Q99714 3/20 0.52
HPGD P15428 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
MEN1 O00255 2/20 0.52
CYP3A4 P08684 2/20 0.52
CYP2D6 P10635 2/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
TTK P33981 1/20 0.45
MAPT P10636 4/20 0.44
TDP1 Q9NUW8 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TP53 P04637 3/20 0.43
XDH P47989 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25720301 0.83 S1PR1 (0.52) KDM4ESMN1; SMN2CYP3A4CYP2D6CYP2C9
SCHEMBL5451902 0.82 IMPDH2 (0.44) HSD17B10MAPTLMNA
SCHEMBL1758642 0.82 F2 (0.52) NPC1RAB9AKMT2ASMN1; SMN2MEN1
SCHEMBL7777657 0.81 PTGS2 (0.50) ALDH1A1KMT2ASMN1; SMN2MEN1MAPT
SCHEMBL11996179 0.80 PDE10A (0.48) ALDH1A1KDM4ESMN1; SMN2CYP3A4CYP2D6
SCHEMBL7780635 0.80 CA2 (0.61) ALDH1A1KMT2ASMN1; SMN2MEN1TTK
SCHEMBL14990810 0.79 CYP3A4 (0.71) ALDH1A1KDM4ENPC1RAB9AKMT2A
SCHEMBL5256518 0.77 NOTUM (0.52) NPC1RAB9AHSD17B10SMN1; SMN2
SCHEMBL27696049 0.77 CNR1 (0.56) ALDH1A1KDM4ENPC1KMT2AHSD17B10
SCHEMBL28804998 0.77 TUBB4A (0.58) KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160058894-A1 RADIOLABELED PDE10A LIGANDS ABBVIE DEUTSCHLAND (DE) 2016-03-03 US disclosed
US-9138494-B2 Radiolabeled PDE10A ligands ABBVIE INC. (US) 2015-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160058894-A1 RADIOLABELED PDE10A LIGANDS PDE10A, PDE3A, PDE5A ALDH1A1 338/4885KDM4E 4115/4885NPC1 664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.